NCRI 2018

The 2018 National Cancer Research Institute (NCRI) Cancer Conference was held in Glasgow, UK, from the 4–6 November. Follow this page for expert interviews and stay up-to-date as breakthrough clinical trial results for oncolytic viruses are discussed, pressing issues on treatment challenges are explored and promising evidence for emerging biomarkers presented.

3:40
The gut microbiome: role in causing and detecting colorectal cancer
Paul O'Toole
2:29
Learning cancer screening programs: why are they needed?
Mette Kalager
1:14
The NCRI: an opportunity for patients and students to gain invaluable skills
Max Williamson
3:10
Understanding the complexity of cancer treatment
Martin Christlieb
1:44
Targeting hypoxia in tumors with combination therapy
Kaye Williams
2:56
Why attend a medical congress: a patient and student perspective
Max Williamson
1:11
Hypoxia in the tumor microenvironment drives radiation resistance
Kaye Williams
4:06
Improving public health: the link between air pollution and cancer is as strong as ever
John Cherrie
3:07
Future uses of ctDNA measurements: changing the treatment landscape
Pierre-Jean Lamy
2:21
Reactivating the host immune response against cancer: new genetic discoveries
Sergio Quezada
4:13
The current discrepancies in cancer care
Nancy Keating
2:12
ctDNA measurement via liquid biopsy: improving cancer detection and diagnosis
Pierre-Jean Lamy
3:28
Advances in immune regulation and tumor immunotherapy
Sergio Quezada
2:33
Benefits of the scientist-patient interaction
Martin Christlieb
1:51
Harm reduction products for cigarette smokers
Lion Shahab
1:31
Role of early lung cancer screening in cigarette smokers
Lion Shahab
The content of VJOncology is intended for healthcare professionals